M. Kulyk & Associates, LLC Novartis Ag Transaction History
M. Kulyk & Associates, LLC
- $446 Million
- Q4 2024
A detailed history of M. Kulyk & Associates, LLC transactions in Novartis Ag stock. As of the latest transaction made, M. Kulyk & Associates, LLC holds 2,398 shares of NVS stock, worth $256,226. This represents 0.05% of its overall portfolio holdings.
Number of Shares
2,398
Previous 2,358
1.7%
Holding current value
$256,226
Previous $271,000
14.02%
% of portfolio
0.05%
Previous 0.06%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,443Shares Held
133MCall Options Held
1.12MPut Options Held
1.61M-
Dodge & Cox San Francisco, CA12.2MShares$1.31 Billion0.85% of portfolio
-
Primecap Management CO Pasadena, CA11MShares$1.18 Billion0.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.09MShares$865 Million0.23% of portfolio
-
Morgan Stanley New York, NY6.98MShares$746 Million0.06% of portfolio
-
Loomis Sayles & CO L P5.77MShares$616 Million0.87% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $230B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...